K2M’s NILE Alternative Fixation Spinal System receives FDA clearance

K2M received 510(k) clearance from the U.S. Food and Drug Administration to market the NILE Alternative Fixation Spinal System.

Advertisement

The system intends to provide stabilization between the spine and the rod, and to allow for reduction, translation, compression and distraction while sparing the anatomy. The system has also received the CE Mark.

 

The first surgical case using NILE in the United States was completed in March by Burt Yaszay, MD, a pediatric orthopedic surgeon, at Rady Children’s Hospital in San Diego.

 

More articles on devices:
Synergy Disc Replacement names GM Medical Pacific exclusive distributor — 5 things to know
7 key trends in the China orthopedic device market
Innovating beyond implants — DePuy Synthes launches data-collection software & patient video

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.